A BioPhorum member only deliverable, the BioPhorum Commercialization workstream has developed a conceptual facility design that deliberately disrupts conventions for flow, segregation and cleanroom classification.
multi-product facilities
Viewing related articles
read more
Risk-based strategies to support revalidation and the assessment of requirements to maintain the validated state of equipment, process and facilities used for commercial and clinical manufacturing
Sep 2022 | Deliverable, Deliverables Report, Drug Substance, Multi-Product Facility, POI - Drug Substance, Publication
This paper describes risk-based alternative strategies for defending the suitability of equipment and facilities requiring revalidation. These robust and risk-assessed approaches include real-time review, routine monitoring and in-/at-line alarms and measurements to help identify what data and testing are critical to assure the continued validated state of the equipment.